Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATYR | AZN | AMGN | GILD | BMY |
| Company | Atyr Pharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.8165 | 186.73 | 353.30 | 141.41 | 59.21 |
| High | 0.8449 | 189.79 | 356.32 | 142.09 | 59.64 |
| Low | 0.7900 | 186.33 | 347.85 | 140.12 | 58.09 |
| Latest | 0.8276 | 188.93 | 349.92 | 141.11 | 58.11 |
| Change | +0.0126 | +0.51 | -1.56 | -0.18 | -1.26 |
| % Change | +1.55% | +0.27% | -0.44% | -0.13% | -2.12% |
| Volume | 1,055,300 | 1,469,957 | 2,168,700 | 7,310,400 | 12,850,610 |
| 20-Day Average Volume | 1,199,150 | 1,837,430 | 2,499,580 | 6,432,110 | 12,374,380 |
| Previous Close | 0.8150 | 188.42 | 351.48 | 141.29 | 59.37 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9271 | 197.95 | 373.04 | 146.36 | 60.54 |
| 20-Day Raw Stochastic | 12.13% | 11.02% | 4.77% | 13.40% | 0.42% |
| 20-Day Relative Strength | 45.47 | 43.41 | 42.69 | 46.90 | 46.57 |
| Weighted Alpha | -12.16 | +28.20 | +15.40 | +34.35 | +6.34 |
| Today's Opinion | 40% Sell | 56% Buy | 56% Buy | 64% Buy | 56% Buy |
| Previous Opinion | 56% Sell | 56% Buy | 56% Buy | 80% Buy | 80% Buy |
| Last Month's Opinion | 8% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.60% since 03/12/26 | -1.85% since 03/12/26 | -4.86% since 03/12/26 | -2.82% since 03/12/26 | -1.42% since 03/12/26 |
| Low | 0.7900 on 03/19/26 | 186.33 on 03/19/26 | 347.85 on 03/19/26 | 139.23 on 03/18/26 | 58.09 on 03/19/26 |
| High | 0.9098 on 03/17/26 | 193.96 on 03/17/26 | 372.98 on 03/13/26 | 148.22 on 03/13/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | -21.18% since 02/19/26 | -9.44% since 02/19/26 | -6.81% since 02/19/26 | -6.62% since 02/19/26 | -3.63% since 02/19/26 |
| Low | 0.7900 on 03/19/26 | 186.33 on 03/19/26 | 347.85 on 03/19/26 | 139.23 on 03/18/26 | 58.09 on 03/19/26 |
| High | 1.1000 on 02/23/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 153.26 on 02/20/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +10.35% since 12/19/25 | +3.40% since 12/19/25 | +6.88% since 12/19/25 | +13.53% since 12/19/25 | +7.23% since 12/19/25 |
| Low | 0.6562 on 01/12/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 1.1100 on 02/19/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -16.58% since 09/19/25 | +23.84% since 09/19/25 | +22.60% since 09/19/25 | +23.68% since 09/19/25 | +29.08% since 09/19/25 |
| Low | 0.6400 on 11/21/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.1200 on 10/10/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 79,912 | 292,222,080 | 189,471,616 | 175,400,352 | 120,905,456 |
| Shares Outstanding, K | 98,051 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 190,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -74,120,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 190,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -25,740,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.55 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 03/05/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/06/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.88 | 16.53 | 17.72 | 9.71 |